(19)
(11) EP 0 967 922 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.05.2010 Bulletin 2010/21

(45) Mention of the grant of the patent:
24.03.2010 Bulletin 2010/12

(21) Application number: 98905021.6

(22) Date of filing: 06.02.1998
(51) International Patent Classification (IPC): 
A61B 17/03(2006.01)
(86) International application number:
PCT/US1998/002483
(87) International publication number:
WO 1998/034546 (13.08.1998 Gazette 1998/32)

(54)

EXPANSILE DEVICE FOR USE IN BLOOD VESSELS AND TRACTS IN THE BODY AND TENSION APPLICATION DEVICE FOR USE THEREWITH

AUSDEHNBARE VORRICHTUNG ZUR ANWENDUNG IN BLUTBAHNEN UND SPANNUNGS APPLIKATOR DER HIERBEI ANGEWENDET WIRD

DISPOSITIF EXPANSIBLE PREVU POUR ETRE UTILISE DANS LES VAISSEAUX ET FAISCEAUX SANGUINS ET SYSTEME D'APPLICATION DE TENSION PREVU POUR ETRE MIS EN OEUVRE AVEC CELUI-CI


(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 11.02.1997 US 798870
18.11.1997 US 972383

(43) Date of publication of application:
05.01.2000 Bulletin 2000/01

(73) Proprietor: Cardiva Medical, Inc
Sunnyvale CA 94085 (US)

(72) Inventors:
  • EPSTEIN, Gordon, H.
    Fremont, CA 94539 (US)
  • LEMPERT, Todd, E.
    Piedmont, CA 94611 (US)
  • MARTIN, Brian, B.
    Boulder Creek, CA 95006 (US)

(74) Representative: Merrifield, Sarah Elizabeth 
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)


(56) References cited: : 
EP-A- 0 534 696
GB-A- 1 169 419
US-A- 5 108 421
US-A- 5 171 259
US-A- 5 258 000
US-A- 5 419 765
US-A- 5 454 833
WO-A-88/09683
US-A- 5 108 420
US-A- 5 108 421
US-A- 5 171 259
US-A- 5 419 765
US-A- 5 454 833
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).